WO2019155266A1 - Flavocillin: a new novel antibitoic that the bacteria will never develop - Google Patents

Flavocillin: a new novel antibitoic that the bacteria will never develop Download PDF

Info

Publication number
WO2019155266A1
WO2019155266A1 PCT/IB2018/050851 IB2018050851W WO2019155266A1 WO 2019155266 A1 WO2019155266 A1 WO 2019155266A1 IB 2018050851 W IB2018050851 W IB 2018050851W WO 2019155266 A1 WO2019155266 A1 WO 2019155266A1
Authority
WO
WIPO (PCT)
Prior art keywords
flavocilin
flavonoid
methods
antibiotic
penicilin
Prior art date
Application number
PCT/IB2018/050851
Other languages
French (fr)
Other versions
WO2019155266A8 (en
Inventor
Mustafa Pehlivan
Original Assignee
Mustafa Pehlivan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mustafa Pehlivan filed Critical Mustafa Pehlivan
Priority to PCT/IB2018/050851 priority Critical patent/WO2019155266A1/en
Priority to EP18713342.6A priority patent/EP3752509A1/en
Publication of WO2019155266A1 publication Critical patent/WO2019155266A1/en
Publication of WO2019155266A8 publication Critical patent/WO2019155266A8/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/74Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with carbocyclic rings directly attached to the carboxamido radical

Definitions

  • Flavocillin A new novel antibitoic that the bacteria will never develop resistance
  • Flavocilin For obtaining Flavocilin, the R group must be replaced with a basic flavonoid and there may be more ways than what is being described at the claims part of this invention. Fortunately, obtaining Flavocilin is a simple Chemical process as a conclusion drawn from its theoretical studies.
  • Flavonoids are very useful antimicrobial compounds of herbal origin found naturally in certain teas and Propolis, a solution available to be used in Medicine which is what the honey bee uses to prevent his honey comb from microbes while producing honey.
  • Propolis alone readily available from Holland and Barret Stores, is full of flavonoids and as such it is effective in treating certain respiratory tract infections and also persistent flue, as a natural remedy.
  • Flavocilin can easily be obtained with simple reactions.
  • Flavocilin can always be used as a final choice of antibiotic where patient responds to no other antibiotic treatment, and it is impossible not to respond to Flavocilin due to dual mechanism of action stated previously.
  • Flavocilin will be the solution for the problem of the century, antibiotic resistance, even after centuries due to penicilin-flavonoid dual strength effects.
  • Flavocilin needs to be tested against virus effectiveness also. Due to its flavonoid group and Penicilin group, it can have a wider range of Pharmacological use and tests can determine if it will cancel, prevent, treat or minimise viral resistance, and if so, to what levels? The likelihood of finding out that it is very powerful against virus also will add benefit to its revolutionary importance and non-competitive unique advantages.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

This invention is about the discovery of a new novel compound as an antibiotic to stop this potential resistance problem completely. With Organic Chemistry studies and methods and other modified antibiotics, adding a flavonoid group to varibale side R instead which will result in flavocilin formation will be the most effective and revolutionary antibiotic that the bacteria will never be able to resist. Evidentful pathways have been conculded stating that the Flavocilin use in Medicine for heavy infectious conditions or where no other antibiotic works will outweigh all its risks.

Description

Flavocillin: A new novel antibitoic that the bacteria will never develop resistance
Resistance to antibiotics is a complicated growing problem of the centruy. Presently, this problem has been so much getting the attention of Medical Research Institutions and health organizations that there is a huge alert in preventing antibiotic resistance. There are reports estimating that many people will die in 2050’s due to antibiotics not working anymore as a result of this resistance. The simplest evidence that Flavocillin will be an effective antibiotic is that many stronger antibiotics were obtained by modifying the variable group (R) in Penicilin Chemical structure.
For obtaining Flavocilin, the R group must be replaced with a basic flavonoid and there may be more ways than what is being described at the claims part of this invention. Fortunately, obtaining Flavocilin is a simple Chemical process as a conclusion drawn from its theoretical studies.
Flavonoids are very useful antimicrobial compounds of herbal origin found naturally in certain teas and Propolis, a solution available to be used in Medicine which is what the honey bee uses to prevent his honey comb from microbes while producing honey. Propolis alone, readily available from Holland and Barret Stores, is full of flavonoids and as such it is effective in treating certain respiratory tract infections and also persistent flue, as a natural remedy.
In drug discovery and development process, adding effective Bioactive compounds to R groups of already active Chemical compounds as drug molecules is important to obtain much stronger effects than that of those drug molecules being used alone in treatment.
Possible advantages and disadvantages of Flavocilin as a new drug
development
Advantages:
Due to dual destructive mechanism effects (Cell wall inhibition and microbial destruction by bioactive flavonoid group as R (variable) group of Penicillin), the bacteria will never have the ability to resist to Flavocilin and therefore it will be the most powerful antibiotic via this defined dual strength of bioactivity.
As suggested in Chemical synthesis route part of claims, Flavocilin can easily be obtained with simple reactions.
Non-competitive advantage for the developer industry or for the drug company as a company holding the license rights of production during 20 years of patent protection. Flavocilin can always be used as a final choice of antibiotic where patient responds to no other antibiotic treatment, and it is impossible not to respond to Flavocilin due to dual mechanism of action stated previously.
Flavocilin will be the solution for the problem of the century, antibiotic resistance, even after centuries due to penicilin-flavonoid dual strength effects.
Flavocilin needs to be tested against virus effectiveness also. Due to its flavonoid group and Penicilin group, it can have a wider range of Pharmacological use and tests can determine if it will cancel, prevent, treat or minimise viral resistance, and if so, to what levels? The likelihood of finding out that it is very powerful against virus also will add benefit to its revolutionary importance and non-competitive unique advantages.
Disadvantages:
Stronger effects may bring further side effects (but as flavonids are naturally found in tea and little or moderate tea consumption is known to have no noticable toxic effects, this risk is not likely).
Clinical testing to fully determine Pharmacological effects have not yet been determined.
Easy making of flavocilin can result in easy illegal flavocilin production (This is a probability but yet it is not very likely as per strict regulationbs and restrictions of patent law and also because a laboratory is still needed for its production although the method is not quite complicated.
References:
1. Nature volume 179, pages 892-893 (04 May 1957) doi: 10.1038/179892a0
2. J. Am. Chem. Soc. , 1957, 79 (5), pp 1262-1263. DOI:
10.1021/ja01562a063
3. Protein Sci. 2009 Mar; 18(3): 595-605. doi: 10.1002/pro.67 PMCID:
PMC2760365

Claims

Claims
1. This invention is about the discovery of a new novel antibiotic of maximum effectiveness that can ever be obtained by simpler than usual Chemical synthesis and modification methods, namely“Flavocilin”.
2. Flavocilin will overcome all the possible and potential antibiotic resistance problems and mechanisms as per stated mechnaisms of action and its unqiue and basic structure will be the strongest antibiotic ever used in Medicine, according to claim 1.
3. Flavocilin will consist of a flavonoid as R group attached to basic penicilin structure, according to claim 2.
4. Flavocilin can simply be obtained/synthesized in a Chemistry laboratory as following moderate detail synthesis methods (Other synthetic methods can also be developed besides this and grams and scales yet need to be determined by expert Organic/synthetic Chemists in field): Any basic flavonoid or a flavone solution is firstly extracted from a herbal tea by using any one of dichloromethane, diethyl ether, chloroform or ethyl acetate as a solvent. There are more than one way of extraction and many of these methods are available from many different public resources. The flavonoid extract is then isolated from the rest of the tea and H2S04 is added to the isolated flavonoid solution to produce lone paired Oxygens (as Flavonoids contain Oxygen around Cyclic carbons). The solution is then reacted with a readily available penicilin powder so that the formed lone pairs around Oxygen(s) in flavonoid attack the carbon attached to NH, O and R groups of Penicilin. This will result in double bond brokage and newly formed bond with the flavonoid due to an SN reaction. Since Penicilin contains Sulphur atom and methyls, an acid or other acidic compounds such as Sulphuric acid is likely to be resulted from this reaction, but such formed acids can easily be removed with the addition of a base to the solution resulting in salt formation that can be extracted and isolated later on so that it is gotten rid as it is unwanted. Finally, identification methods such as High Performance Liquid Chromatography (HPLC) and Carbon NMR must be used to analyze the solution to ensure the finally obtained sample contains Flavocilin and to ensure its structure represents the Flavocilin structure as identified in figure 2 of drwaings part of the invention. Once this is ensured, the very final step of the process is to purify the sample with purification methods to obtain 99% Flavocilin. Alternative synthetic routes or pathways at any stage is also possible.
PCT/IB2018/050851 2018-02-12 2018-02-12 Flavocillin: a new novel antibitoic that the bacteria will never develop WO2019155266A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2018/050851 WO2019155266A1 (en) 2018-02-12 2018-02-12 Flavocillin: a new novel antibitoic that the bacteria will never develop
EP18713342.6A EP3752509A1 (en) 2018-02-12 2018-02-12 Flavocillin: a new penicillin derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2018/050851 WO2019155266A1 (en) 2018-02-12 2018-02-12 Flavocillin: a new novel antibitoic that the bacteria will never develop

Publications (2)

Publication Number Publication Date
WO2019155266A1 true WO2019155266A1 (en) 2019-08-15
WO2019155266A8 WO2019155266A8 (en) 2020-06-18

Family

ID=61768349

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2018/050851 WO2019155266A1 (en) 2018-02-12 2018-02-12 Flavocillin: a new novel antibitoic that the bacteria will never develop

Country Status (2)

Country Link
EP (1) EP3752509A1 (en)
WO (1) WO2019155266A1 (en)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANA CRISTINA ABREU ET AL: "Combinatorial Activity of Flavonoids with Antibiotics Against Drug-Resistant Staphylococcus aureus", MICROBIAL DRUG RESISTANCE., vol. 21, no. 6, 1 December 2015 (2015-12-01), US, pages 600 - 609, XP055474797, ISSN: 1076-6294, DOI: 10.1089/mdr.2014.0252 *
J. AM. CHEM. SOC., vol. 79, no. 5, 1957, pages 1262 - 1263
NATURE, vol. 179, 4 May 1957 (1957-05-04), pages 892 - 893
PROTEIN SCI., vol. 18, no. 3, March 2009 (2009-03-01), pages 595 - 605

Also Published As

Publication number Publication date
EP3752509A1 (en) 2020-12-23
WO2019155266A8 (en) 2020-06-18

Similar Documents

Publication Publication Date Title
Ebiloma et al. Bioassay-guided isolation of active principles from Nigerian medicinal plants identifies new trypanocides with low toxicity and no cross-resistance to diamidines and arsenicals
CN105503531A (en) Extract of fungus culture as well as preparation method and application of extract
WO2019155266A1 (en) Flavocillin: a new novel antibitoic that the bacteria will never develop
CN102276632A (en) Praziquantel derivative as well as preparation and application thereof
Parmar et al. Mast cell membrane stabilization and anti-histaminic actions possible mechanism of action of anti-inflammatory action of Murraya koenigii
RU2572231C1 (en) Method for producing antibacterial preparation of manna gum leaves
CN107212029A (en) Herba Agrimoniae extract is being prepared for removing the application in tomato plant in the medicine of plant virus
RU2519666C1 (en) Agent showing anti-opisthorchiasis action, and method for preparing it
CN101385796B (en) New use of a formulation in improving cognition dysfunction and preventing and treating senile dementia
CN109496211B (en) Piperazine derivative for resisting candida albicans as well as preparation method and application thereof
RU2615356C1 (en) Method for lutenurinum preparation manufacture from yellow water-lily (nuphar lutea (l) smith)
Marks Sea Lavender Endophyte's
Okere et al. Antibacterial and antifungal activity of methanolic leaf extract of Allium sativum on selected pathogenic strains
Banerjee et al. A STUDY TO EVALUATE THERAPEUTIC POTENTIAL OF POGOSTEMON CABLIN OIL AGAINST EXPERIMENTALLY INDUCED ALZHEIMER’S DISEASE IN MICE
Devi et al. Organic solvents can influence acetylcholine neurotransmission in Caenorhabditis elegans
RU2664453C1 (en) Derivative of 3-hydroxypyridine with anxiolytic and nootropic effect
Innocent et al. SYSTEMATIC ANALYSIS OF ANTIBACTERIAL ACTIVITY OF PLANT EXTRACTS FROM PHYTOLACCA DODECANDRA AND DATURA STRAMONIUM
Ganaie Fungal Diseases of Animals: Symptoms and Their Cure by Natural Products
WO2023237795A1 (en) Use of the (+)-elatol compound for treating or preventing a naegleria fowleri infection
CN102091105B (en) New application of field pennycress and preparation thereof
Aleksandrova et al. Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases
Agbafor et al. Catalase and superoxide dismutase (SOD) activity in albino rats treated with aqueous leaf extract of ageratum conyzoides
Mogaka et al. Evaluation of the Therapeutic Potential of Warburgia ugandensis, Prunus africana, and Piliostigma thonningii against Leishmania donovani in vitro and in Balb/c Mice
BR102019014583A2 (en) methodology of the process of biosynthesis of secondary metabolites of endophytic fungi with inhibitory activity against caseous lymphadenitis
Kang et al. A study of the biodiversity and secondary metabolites of fungal endophytes from medicinal plants in Guizhou

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18713342

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2018713342

Country of ref document: EP

Effective date: 20200914